Sedentary behaviour has unclear link with prostate cancer risk

Sedentary behaviour is not a clearcut risk factor for prostate cancer, analysis of a large population-based cohort indicates.
Source: MedWire News - Urology - Category: Urology & Nephrology Source Type: news

Related Links:

A video about the risks and benefits of germline testing in prostate cancer could help cancer practices ease problems caused by a shortage of trained genetic counselors.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Condition:   Prostate Adenocarcinoma Interventions:   Drug: Bicalutamide;   Drug: Buserelin;   Drug: Darolutamide;   Drug: Degarelix;   Drug: Flutamide;   Drug: Goserelin;   Drug: Histrelin;   Drug: Leuprolide;   Radiation: Radiation Therapy;   Drug: Relugolix;   Drug: Triptorelin Sponsors:   NRG Oncology;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Androgen deprivation alone is no longer an acceptable option for the treatment of men with metastatic castration-sensitive prostate cancer (mCSPC), experts contend.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Evid Based Complement Alternat Med. 2021 Sep 9;2021:7767186. doi: 10.1155/2021/7767186. eCollection 2021.ABSTRACTOBJECTIVE: To explore the efficacy of Internet-based chronic disease management model combined with the modified therapy of Bushenyiliu decoction in treating patients with type 2 diabetes mellitus (T2DM) and prostate cancer and its effect on disease control rate (DCR).METHODS: 120 patients with T2DM and prostate cancer admitted to the Affiliated Hospital of Yangzhou University, Yangzhou First People's Hospital, from February 2019 to February 2020, were retrospectively analyzed and equally divided into the experi...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Authors: Source Type: research
Br J Radiol. 2021 Sep 19:20210653. doi: 10.1259/bjr.20210653. Online ahead of print.ABSTRACTFor assessing a cancer treatment, and for detecting and characterizing cancer, Diffusion-weighted imaging (DWI) is commonly used. The key in DWI's use extracranially has been due to the emergence of of high-gradient amplitude and multichannel coils, parallelimaging, and echo-planar imaging. The benefit has been fewer motion artefacts and high-quality prostate images.Recently, new techniques have been developed to improve the signal-to-noise ratio of DWI with fewer artefacts, allowing an increase in spatial resolution. For apparent d...
Source: The British Journal of Radiology - Category: Radiology Authors: Source Type: research
Urol Oncol. 2021 Sep 16:S1078-1439(21)00376-8. doi: 10.1016/j.urolonc.2021.08.013. Online ahead of print.ABSTRACTPURPOSE/OBJECTIVE: Risk-stratification for post-prostatectomy radiotherapy (PORT) using conventional clinicopathologic indexes leads to substantial over- and under-treatment. Better patient selection could spare unnecessary toxicities and improve outcomes. We investigated the prognostic utility of unfavorable subpathologies intraductal carcinoma and cribriform architecture (IDC/CA), and a 22-gene Decipher genomic classifier (GC) in prostate cancer (PCa) patients receiving PORT.MATERIAL/METHODS: A cohort of 302 m...
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research
This study included AS patients with biopsy-proven PCa with a minimum of two consecutive MR examinations and at least one repeat targeted biopsy. Tumour volumes, largest axial two-dimensional (2D) surface areas, and maximum diameters were measured on T2 weighted images (T2WI). ADC values were derived from the whole lesions, 2D areas, and small-volume regions of interest (ROIs) where tumours were most conspicuous. Areas under the ROC curve (AUCs) were calculated for combinations of T2WI and ADC parameters with optimal specificity and sensitivity.RESULTS: 60 patients (30 progressors and 30 non-progressors) were included. In ...
Source: The British Journal of Radiology - Category: Radiology Authors: Source Type: research
CONCLUSIONS: mpMRI-guided focal boost using VMAT hypofractionated technique is associated with an excellent morphological and functional response control and a safe toxicity profile.ADVANCES IN KNOWLEDGE: In the present trial, we examined the potential role of mpMRI for radiological assessment (functional and morphological) of treatment response in high-risk prostate cancer patients treated with MRI-guided focal radiotherapy dose intensification to dominant Intraprostatic lesion.PMID:34538073 | DOI:10.1259/bjr.20210683
Source: The British Journal of Radiology - Category: Radiology Authors: Source Type: research
Prostate cancer currently has the highest positive surgical margin rate of any cancer in men, with 21% of patients left with cancer cells at the resection site Cancer surgeons may soon have a new technology to help them completely remove cancerous tissue during prostate cancer surgery. Called Cerenkov luminescence imaging (CLI), this new diagnostic technology […] The post German Feasibility Study Shows Cerenkov Luminescence Imaging May Provide New Technique for Identifying Positive Margins during Prostatectomies appeared first on Dark Daily.
Source: Dark Daily - Category: Laboratory Medicine Authors: Tags: Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory News Laboratory Pathology Laboratory Testing Managed Care Contracts & Payer Reimbursement anatomic pathology Boris A. Hadaschik PhD Cerenkov luminescence imagin Source Type: news
More News: Cancer | Cancer & Oncology | Prostate Cancer | Urology & Nephrology